| Jeffrey S Fitzgerald, MD | |
|
969 Lakeland Dr, Jackson, MS 39216-4606 | |
| (601) 200-6175 | |
| (601) 200-2020 |
| Full Name | Jeffrey S Fitzgerald |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 22 Years |
| Location | 969 Lakeland Dr, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164449740 | NPI | - | NPPES |
| 07753816 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 18973 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Relias Emergency Medicine Specialists Of St Dominic Llc | 2466840152 | 17 |
News Archive
Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
› Verified 5 days ago
| Entity Name | First Intermed Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669406658 PECOS PAC ID: 5294629895 Enrollment ID: O20040213000105 |
News Archive
Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
› Verified 5 days ago
| Entity Name | St. Dominic Jackson Memorial |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235173691 PECOS PAC ID: 4385531847 Enrollment ID: O20040301000818 |
News Archive
Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
› Verified 5 days ago
| Entity Name | Relias Emergency Medicine Specialists Of St Dominic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235808122 PECOS PAC ID: 2466840152 Enrollment ID: O20211029000889 |
News Archive
Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey S Fitzgerald, MD Po Box 23457, Jackson, MS 39225-3457 Ph: (601) 200-6175 | Jeffrey S Fitzgerald, MD 969 Lakeland Dr, Jackson, MS 39216-4606 Ph: (601) 200-6175 |
News Archive
Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.
BG Medicine, a life sciences company focused on the discovery, development, and commercialization of novel diagnostics based on biomarkers, today announced the issuance of U.S. Patent No. 7,888,137, entitled "Method For Identifying a Subject at Risk of Developing Heart Failure by Determining the Level of Galectin-3 or Thrombospondin-2" to the University of Maastricht. BG Medicine has an exclusive license to this issued patent, which pertains to galectin-3 testing for individuals at risk for heart failure.
Scientists from the University of Aberdeen, the Aberdeen-based Rowett Research Institute and the Medical Research Council (MRC) in Cambridge have made a major breakthrough in understanding how metabolism affects lifespan.
End stage kidney disease is a global public health problem with an estimated 2.4 million patients on dialysis. The number of new cases is rising (7-8% annually) due to population ageing and increased diabetes prevalence.
Plenty of hospitals and medical providers claim they do a great job at caring for patients and protecting their safety during care. But very few actually publish the cold, hard numbers that could prove those claims. And even fewer do it like the University of Michigan Health System has: on a website open to anyone, with dozens of charts and graphs showing actual performance and comparisons to national averages and benchmarks.
› Verified 5 days ago
Laura Elizabeth Vearrier, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-2005 | |
Dr. Melanie Fox, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Mohsin Saber, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 N State St, Department Of Emergency Medicine, Jackson, MS 39201 Phone: 601-984-5582 Fax: 601-984-5583 | |
Dr. Gabriel William Tonkin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 N. State St., Dept. Of Emergency Medicine, Jackson, MS 39216 Phone: 601-984-5582 | |
John C Brooks, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1225 N State St, Jackson, MS 39202 Phone: 601-982-6001 Fax: 601-982-8616 | |
Bob Hutchins, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3502 W Northside Dr, Jackson, MS 39213 Phone: 601-362-5321 Fax: 601-364-2600 | |
Lana Ngoc Phan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1850 Chadwick Dr, Jackson, MS 39204 Phone: 601-376-1000 |